Antero Resources Corp (AR) Stock News

BARK reported Q1 fiscal 2027 revenue of $78.8 million, down 23.4% year-over-year due to a deliberate pullback in marketing spend and smaller subscriber base. However, the company showed positive underlying metrics with subscriber retention improving 170+ basis points to 92.8%, average order value increasing $0.45, and adjusted EBITDA growing to $0.6 million. Management reiterated full-year guidance of $325-340 million revenue and $7-10 million adjusted EBITDA, expressing confidence in returning to growth in the second half of fiscal 2027 driven by new product launches (Lixters enrichment toys), retail partnerships (Crocs, Liquid Death), and strong BARK Air performance.

A new report examines national security concerns over Chinese dominance in the humanoid and quadruped robotics market, where Chinese companies account for ~90% of global shipments. The GUARD Act is proposed to restrict adversarial-linked robotics equipment from federal procurement, potentially reshaping the market and creating opportunities for U.S. and allied manufacturers while establishing clearer federal standards for secure robotics systems.

Crédit Agricole Brie Picardie reported weekly share buybacks conducted under MAR Regulation Article 5 from August 3-7, 2026, with volumes ranging from 1,537 to 3,692 shares daily at prices between €36.41 and €36.89. The company's Board of Directors met on July 29, 2026 to approve semi-annual financial statements as of June 30, 2026.

Rosen Law Firm has filed a class action lawsuit against Alarum Technologies Ltd. (NASDAQ: ALAR) on behalf of investors who purchased securities between March 20, 2025 and July 2, 2026. The lawsuit alleges that defendants made false and misleading statements regarding a subsidiary's illegal activity of linking customer home internet devices into another network without consent, which heightened legal exposure and threatened business prospects. Investors who purchased during the class period may be entitled to compensation.

A securities class action lawsuit has been filed against Alarum Technologies Ltd. (NASDAQ: ALAR) for allegedly failing to disclose that its subsidiary NetNut was engaging in illegal activity by linking customer home internet devices into another network without consent, enabling cybercriminals to conceal their locations. The lawsuit covers investors who purchased shares between March 20, 2025 and July 2, 2026.

Klépierre, Europe's leading shopping mall operator, has raised its full-year 2026 guidance with EBITDA expected to reach a minimum of €1,150 million. The company demonstrated strong execution in a dynamic retail market, driving organic growth. As of July 31, 2026, the company had 286.86 million shares outstanding.

Rosen Law Firm has filed a class action lawsuit against Alarum Technologies Ltd. (NASDAQ: ALAR) on behalf of investors who purchased securities between March 20, 2025 and July 2, 2026. The lawsuit alleges that defendants made false and misleading statements regarding a subsidiary's illegal activity of linking customer home internet devices into another network without consent, which heightened legal exposure and threatened business prospects. Investors with losses exceeding $100,000 are encouraged to seek counsel before the October 5, 2026 deadline to serve as lead plaintiff.

A class action lawsuit has been filed against Alarum Technologies Ltd (NASDAQ: ALAR) for allegedly making false and misleading statements regarding its subsidiary NetNut's illegal activity of linking customer home internet devices to networks without consent. The complaint alleges this activity facilitated cybercriminal operations and materially heightened the company's legal exposure. Investors who purchased Alarum securities between March 20, 2025 and July 2, 2026 can join the lawsuit, with a lead plaintiff deadline of October 5, 2026.

A securities class action lawsuit has been filed against ARS Pharmaceuticals Inc. for allegedly providing misleading statements about expanded insurance coverage for its epinephrine nasal spray product neffy through CVS Caremark. The company failed to disclose risks that the July 1, 2026 coverage deadline might not be met. When the truth emerged on June 24, 2026, ARS stock declined over 23.9% in a single day.

ARCpoint Inc. (TSXV: ARC) announced that the British Columbia Securities Commission issued a failure-to-file cease trade order on August 5, 2026, due to the company's failure to file audited annual financial statements for the year ended March 31, 2026, by the July 29 deadline. The cease trade order prohibits all trading in the company's Class A Subordinate Voting Shares. The delay stems from the company's lack of available funds to pay auditors and accounting personnel. Trading remains suspended until the company files the required documents and the BCSC revokes the order.

Kirby McInerney LLP is investigating Jefferies Financial Group for potential securities law violations related to alleged misleading disclosures about the company's exposure to First Brands Group, a bankrupt auto-parts supplier, through its asset-management unit Point Bonita Capital. The SEC is reportedly investigating claims that Jefferies misled investors, with Point Bonita funds owed approximately $715 million from companies that purchased First Brands' parts. Jefferies disclosed a $30 million loss tied to First Brands' collapse, and the stock declined 9% on the news.

Law firm Levi & Korsinsky has filed a class action lawsuit against ARS Pharmaceuticals for allegedly making false and misleading statements regarding expanded insurance coverage for its drug neffy through CVS Caremark. The company failed to meet its July 1, 2026 deadline for coverage expansion, causing the stock to plummet 23.9% on June 25, 2026. Investors who purchased securities between March 9 and June 24, 2026 can join the lawsuit with a lead plaintiff deadline of October 5, 2026.

Wolf Popper LLP filed a securities class action lawsuit against Smartsheet Inc. on behalf of shareholders who sold stock between June 1 and September 23, 2024. The lawsuit alleges that Smartsheet failed to disclose material information about acquisition offers from Blackstone and Vista Equity Partners ($56.25-$56.50 per share) while simultaneously repurchasing its own stock at significantly lower market prices (~$46.45 average). The merger eventually closed on January 22, 2025, at $56.50 per share.

Crédit Agricole S.A. reports strong activity in Q2 2026 and announces acceleration of its AI transformation initiatives. The company maintains its capital structure with 3,025,902,350 total shares and 3,025,634,720 exercisable voting rights as of July 31, 2026.

Rosen Law Firm has filed a class action lawsuit against Pentwater Capital Management LP and its CEO Matthew Halbower, alleging they orchestrated a market manipulation scheme involving Avis Budget Group securities. The defendants allegedly used their position as a major shareholder (holding ~51% economic interest) to aggressively purchase Avis stock during February 2025 to April 2026, triggering a short squeeze and artificial price volatility that benefited their holdings. Investors who purchased Avis securities during this period may be eligible for compensation.

Class action law firm Monteverde & Associates PC is investigating four merger and acquisition transactions: Planet 13 Holdings' merger with Vireo Growth, Olin Corporation's merger with Huntsman Corporation, and First Seacoast Bancorp's sale to Cambridge Financial Group. The firm is encouraging shareholders to contact them regarding potential concerns with these deals.

Bernstein Liebhard LLP, an investor rights law firm, has announced investigations into potential breaches of fiduciary duty by directors and officers at AeroVironment, Capricor Therapeutics, and Calix. The firm is seeking to determine whether company leadership fulfilled obligations to shareholders and whether legal remedies may be available. Current shareholders are encouraged to contact the firm for consultation.

Bernstein Liebhard LLP has filed securities class action lawsuits against Avis Budget Group for allegedly orchestrating a market manipulation scheme involving short squeezes, and is investigating potential breaches of fiduciary duty at Capricor Therapeutics and Calix. Investors who suffered losses during the specified periods are encouraged to participate in the class actions.

Bernstein Liebhard LLP announced an investigation into potential breaches of fiduciary duty by directors and officers of Gartner, Inc. The law firm is seeking to determine whether company leadership fulfilled its obligations to shareholders. The investigation targets shareholders who purchased shares before February 24, 2025.

Bernstein Liebhard LLP has launched investigations into potential breaches of fiduciary duty by directors and officers at CarMax, Inc., Capricor Therapeutics, Inc., and Calix, Inc. The firm is seeking to determine whether company leadership acted in shareholders' best interests and is encouraging affected shareholders to contact them for legal consultation.

Bernstein Liebhard LLP announced an investigation into potential breaches of fiduciary duty by directors and officers of Calix, Inc. The law firm is seeking to determine whether company leadership fulfilled its obligations to shareholders. The investigation focuses on shareholders who purchased shares before January 28, 2026.

VINCI, a French public limited company, disclosed its capital structure as of 31 July 2026, with 587,033,654 total shares and €1,467,584,135.00 in share capital. The company announced the implementation of its share buyback programme through a share purchase agreement signed with an investment partner.

The Rosen Law Firm has announced an investigation into Alarum Technologies Ltd. (NASDAQ: ALAR) for allegedly issuing materially misleading business information. The investigation was triggered after Alarum disclosed on July 2, 2026, that the FBI seized certain domains associated with its subsidiary NetNut Ltd. Following this disclosure, Alarum's stock fell 51.49% on July 6, 2026. The firm is preparing a class action lawsuit to recover investor losses.

State Street's XAR and First Trust's MISL offer different approaches to aerospace and defense sector exposure. XAR uses an equal-weighted strategy with lower fees (0.35% expense ratio) and broader mid-cap/small-cap exposure, delivering stronger 1-year returns of 20.6%. MISL employs market-cap weighting with higher concentration in defense giants and tech companies, offering lower volatility but higher fees (0.6%) and lower returns (9.6%). For most long-term investors, XAR's lower costs and stronger performance make it the more practical choice.

Law firm Julie & Holleman is investigating Personalis' proposed acquisition by Tempus AI for $16.25 per share, raising concerns about fair value and potential conflicts of interest given Tempus' existing significant equity stake and strategic partnership with Personalis since 2023.

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary focus is on Erasca, Inc., which allegedly made false and misleading statements about its lead oncology drug candidate ERAS-0015, claiming it was 'best-in-class' while failing to disclose improper comparisons to competitors and lacking reasonable basis. The firm is seeking lead plaintiffs with an August 10, 2026 deadline for Erasca and August 4, 2026 for PicS N.V.

The Rosen Law Firm announced an investigation into potential securities claims against Alarum Technologies Ltd. (NASDAQ: ALAR) for allegedly issuing materially misleading business information. The investigation was triggered after Alarum disclosed on July 2, 2026, that the FBI seized domains associated with its subsidiary NetNut Ltd. The stock fell 51.49% on July 6, 2026, following the announcement. The firm is preparing a class action lawsuit to recover investor losses.

Law firm Kirby McInerney LLP is investigating potential securities fraud claims against Alnylam Pharmaceuticals following the company's announcement on July 30, 2026, that it lowered TTR product sales guidance by approximately $200 million due to normalization of growth in the ATTR-CM market after satisfying pent-up demand. The stock fell 28% ($81.14 per share) to $205.48 on the news.

Arval, a BNP Paribas subsidiary, has completed its acquisition of Athlon (formerly a Mercedes-Benz Group subsidiary), creating a European co-leader in long-term vehicle leasing with a combined fleet of 2.3 million vehicles. The transaction is expected to deliver an 18% ROIC and contribute approximately €200 million to net income by year 3, with a modest -13 bps CET1 impact.

Arval, a BNP Paribas subsidiary, has completed its acquisition of Athlon (formerly Mercedes-Benz Group's subsidiary) on July 31, 2026. The combined entity now manages 2.3 million vehicles, establishing itself as a co-leader in European long-term vehicle leasing. The acquisition is expected to deliver an 18% return on invested capital and contribute approximately €200 million to net income by year three, with a -13 basis point impact on the CET1 ratio.